187 related articles for article (PubMed ID: 25208073)
1. Personalized medicine: Special treatment.
Eisenstein M
Nature; 2014 Sep; 513(7517):S8-9. PubMed ID: 25208073
[No Abstract] [Full Text] [Related]
2. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
[TBL] [Abstract][Full Text] [Related]
3. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Preface.
Ahmad A; Gadgeel SM
Adv Exp Med Biol; 2016; 890():v-vi. PubMed ID: 27119128
[No Abstract] [Full Text] [Related]
4. Dearth of clinically useful diagnostics limits growth of personalized medicine.
Cohen J
Expert Rev Clin Pharmacol; 2011 Sep; 4(5):527-9. PubMed ID: 22220302
[No Abstract] [Full Text] [Related]
5. Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine research.
Matos A; Dow P; Bingham JM; Michaud V; Lesko LJ; Knowlton CH; Turgeon J
Pharmacogenomics; 2021 Aug; 22(12):731-735. PubMed ID: 34284600
[No Abstract] [Full Text] [Related]
6. Opinion Paper: Modular Drug Delivery Systems for Personalized Oral Dosage Forms.
Colombo P
Recent Pat Drug Deliv Formul; 2016; 10(1):3. PubMed ID: 26063397
[No Abstract] [Full Text] [Related]
7. Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management.
Soni A; Gowthamarajan K; Radhakrishnan A
Int J Pharm Compd; 2018; 22(2):108-121. PubMed ID: 29877858
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics: Chasing Perfection.
Gaedigk A
Clin Pharmacol Ther; 2019 Aug; 106(2):265-270. PubMed ID: 31355458
[No Abstract] [Full Text] [Related]
9. Current practice in and considerations for personalized medicine in lung cancer: From the patient's molecular biology to patient values and preferences.
Carrera PM; Ormond M
Maturitas; 2015 Sep; 82(1):94-9. PubMed ID: 25981825
[TBL] [Abstract][Full Text] [Related]
10. Successes and limitations of targeted cancer therapy in lung cancer.
Suda K; Mitsudomi T
Prog Tumor Res; 2014; 41():62-77. PubMed ID: 24727987
[TBL] [Abstract][Full Text] [Related]
11. Personalized prediction of EGFR mutation-induced drug resistance in lung cancer.
Wang DD; Zhou W; Yan H; Wong M; Lee V
Sci Rep; 2013 Oct; 3():2855. PubMed ID: 24092472
[TBL] [Abstract][Full Text] [Related]
12. Toward dynamical systems medicine: personalized and preventive strategies.
Yan Q
Per Med; 2017 Sep; 14(5):551-554. PubMed ID: 29754568
[No Abstract] [Full Text] [Related]
13. Precision Medicine in Lung Cancer Treatment.
Shah DR; Masters GA
Surg Oncol Clin N Am; 2020 Jan; 29(1):15-21. PubMed ID: 31757310
[TBL] [Abstract][Full Text] [Related]
14. [Personalized targeted therapy for lung cancer].
Wu K; House L; Liu W; Cho WC
Zhongguo Fei Ai Za Zhi; 2013 Aug; 16(8):C21-34. PubMed ID: 23945250
[TBL] [Abstract][Full Text] [Related]
15. From genomes to genomic medicine: enabling personalized and precision medicine in the Middle East.
Jithesh PV; Scaria V
Per Med; 2017 Sep; 14(5):377-382. PubMed ID: 29754564
[No Abstract] [Full Text] [Related]
16. Personalized therapy for lung cancer.
Moreira AL; Eng J
Chest; 2014 Dec; 146(6):1649-1657. PubMed ID: 25451351
[TBL] [Abstract][Full Text] [Related]
17. The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy.
Sharma J; Shum E; Chau V; Paucar D; Cheng H; Halmos B
Respiration; 2017; 93(1):1-14. PubMed ID: 27894113
[No Abstract] [Full Text] [Related]
18. Pharmacogenetics and personalized medicine. Are expectations being met?
Gervasini G
Med Clin (Barc); 2019 May; 152(9):368-371. PubMed ID: 30611536
[No Abstract] [Full Text] [Related]
19. Personalized medicine in lung cancer: what we need to know.
Mok TS
Nat Rev Clin Oncol; 2011 Aug; 8(11):661-8. PubMed ID: 21862980
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer patients with an abnormal gene benefit from targeted therapy.
Printz C
Cancer; 2013 Oct; 119(20):3582. PubMed ID: 24101567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
